HOMOEOPATHIC MANAGEMENT OF TARGETED HAEMARTHROSES IN INHIBITOR POSITIVE HAEMOPHILIAC: A CASE REPORT

Omkar Kumat; Tapas Kundu; Gulfisha Mirza; Rita Kundu

doi:10.29121/granthaalayah.v11.i12.2023.5422

Authors

Omkar Kumat Communication Consultant, Homoeopathy in Haemophilia, C/O Sakha the Centre of Research and Charity, Upnagar, Nashik, Maharashtra, India
Dr. Tapas Kundu Principal Investigator, Homoeopathy in Haemophilia, C/O Sakha the Centre of Research and Charity, Upnagar, Nashik, Maharashtra, India https://orcid.org/0000-0002-3380-3059
Gulfisha Mirza Research Associate, Homoeopathy in Haemophilia, C/O Sakha the Centre of Research and Charity, Upnagar, Nashik, Maharashtra, India
Rita Kundu Coordinator, Homoeopathy in Haemophilia, C/O Sakha the Centre of Research and Charity, Upnagar, Nashik, Maharashtra, India

DOI:

https://doi.org/10.29121/granthaalayah.v11.i12.2023.5422

Keywords:

Homoeopathy, Hemophilia, Target Joint, Inhibitor, Hemarthroses

Abstract [English]

Haemarthroses is common presentation in haemophilia patient. Due to recurrent use of clotting factor concentrates for treatment and prophylaxis, of which about 20 % of patients produce antibodies to factor VIII and factor IX. This results in development of inhibitors in such patients which complicates the case even more. Homoeopathy the alternative form of treatment can be used in such case. This case report presents the management of haemarthroses in a haemophilia inhibitor. Well selected homoeopathic similimum helped in reversing the haemophilic arthropathy in left knee joint of the patient and even controlled the recurrence of the haemarthroses in target joint. The result was assessed using Hemophilia joint health assessment scale (HJHS). The result of before and after treatment was extremely significant with a p value of 0.0009 The individual curative response of the case was assessed using Modified naranjo criteria for homoeopathic case reporting, casual attribution (MONARCH).

Downloads

Download data is not yet available.

References

Buzzard, B. M., & Jones, P. M. (1988). Physiotherapy Management of Haemophilia: An Update. Physiotherapy, 74(5), 221-226. https://doi.org/10.1016/S0031-9406(10)63535-3 DOI: https://doi.org/10.1016/S0031-9406(10)63535-3

Buzzard, B., & Beeton, K. (2008). Physiotherapy Management of Haemophilia. John Wiley & Sons.

Hermans, C., De Moerloose, P., Fischer, K., Holstein, K., Klamroth, R., Lambert, T., Lavigne-Lissalde, G., Perez, R., Richards, M., Dolan, G. & European Haemophilia Therapy Standardisation Board. (2011). Management of Acute Haemarthrosis in Haemophilia a Without Inhibitors: Literature Review, European Survey and Recommendations. Haemophilia, 17(3), 383-392. https://doi.org/10.1111/j.1365-2516.2010.02449.x DOI: https://doi.org/10.1111/j.1365-2516.2010.02449.x

Lafeber, F. P. J. G., Miossec, P., & Valentino, L. A. (2008). Physiopathology of Haemophilic Arthropathy. Haemophilia, 14, 3-9. https://doi.org/10.1111/j.1365-2516.2008.01732.x DOI: https://doi.org/10.1111/j.1365-2516.2008.01732.x

Lamba, C. D., Gupta, V. K., van Haselen, R., Rutten, L., Mahajan, N., Molla, A. M., & Singhal, R. (2020). Evaluation of the Modified Naranjo Criteria for Assessing Causal Attribution of Clinical Outcome to Homeopathic Intervention as Presented in Case Reports. Homeopathy, 109(04), 191-197. https://doi.org/10.1055/s-0040-1701251 DOI: https://doi.org/10.1055/s-0040-1701251

Minno, M. D., Minno, G. D., Capua, M. D., Cerbone, A. M., & Coppola, A. (2010). Cost of Care of Haemophilia with Inhibitors. Haemophilia, 16(1), e190-e201. https://doi.org/10.1111/j.1365-2516.2009.02100.x DOI: https://doi.org/10.1111/j.1365-2516.2009.02100.x

Morfini, M., Haya, S., Tagariello, G., Pollmann, H., Quintana, M., Siegmund, B., Stieltjes, N., & Tusell, J. (2007). European study on orthopaedic status of haemophilia patients with inhibitors. Haemophilia, 13(5), 606-612. https://doi.org/10.1111/j.1365-2516.2007.01518.x DOI: https://doi.org/10.1111/j.1365-2516.2007.01518.x

Nilsson, I. M., Berntorp, E., Löfqvist, T., & Pettersson, H. (1992). Twenty-five Years' Experience of Prophylactic Treatment in Severe Haemophilia A and B. Journal of Internal Medicine, 232(1), 25-32. https://doi.org/10.1111/j.1365-2796.1992.tb00546.x DOI: https://doi.org/10.1111/j.1365-2796.1992.tb00546.x

Rodriguez-Merchan, E. C., Wiedel, J. D., Wallny, T., Hvid, I., Berntorp, E., Rivard, G. E., Goddard, J., Querol, F., & Caviglia, H. (2003). Elective Orthopaedic Surgery for Inhibitor Patients. Haemophilia, 9(5), 625-631. https://doi.org/10.1046/j.1365-2516.2003.00803.x DOI: https://doi.org/10.1046/j.1365-2516.2003.00803.x

Rodriguez-Merchan, E., Jimenez-Yuste, V., Aznar, J. A., Hedner, U., Knobe, K., Lee, C. A., Ljung, R., Querol, F., Santagostino, E., Valentino, L. A. & Caffarini, A. (2011). Joint protection in haemophilia. Haemophilia, 17, 1-23. https://doi.org/10.1111/j.1365-2516.2011.02615.x DOI: https://doi.org/10.1111/j.1365-2516.2011.02615.x

Rodríguez-Merchán, E. C. (2019). The Role of Orthopaedic Surgery in Haemophilia: Current Rationale, Indications and Results. EFORT Open Reviews, 4(5), 165-173. https://doi.org/10.1302/2058-5241.4.180090 DOI: https://doi.org/10.1302/2058-5241.4.180090

Roosendaal, G., Jansen, N. W. D., Schutgens, R., & Lafeber, F. P. J. G. (2008). Haemophilic Arthropathy: the Importance of the Earliest Haemarthroses and Consequences for Treatment. Haemophilia, 14, 4-10. https://doi.org/10.1111/j.1365-2516.2008.01882.x DOI: https://doi.org/10.1111/j.1365-2516.2008.01882.x

St-Louis, J., Abad, A., Funk, S., Tilak, M., Classey, S., Zourikian, N., McLaughlin, P., Lobet, S., Hernandez, G., Akins, S., Wells, A. J., Manco-Johnson, M., John, J., Austin, S., Chowdary, P., Hermans, C., Nugent, D., Bakeer, N., Mangles, S., Hilliard, P., Blanchette, V.S., Feldman, B. M., & Feldman, B. M. (2022). The hemophilia joint health score version 2.1 validation in adult patients study: a multicenter international study. Research and practice in thrombosis and haemostasis, 6(2). https://doi.org/10.1002/rth2.12690 DOI: https://doi.org/10.1002/rth2.12690

Valentino, L. A., Hakobyan, N., Enockson, C., Simpson, M. L., Kakodkar, N. C., Cong, L., & Song, X. (2012). Exploring the Biological Basis of Haemophilic Joint Disease: Experimental Studies. Haemophilia, 18(3), 310-318. https://doi.org/10.1111/j.1365-2516.2011.02669.x DOI: https://doi.org/10.1111/j.1365-2516.2011.02669.x

Van Haselen, R. A. (2016). Homeopathic Clinical Case Reports: Development of a Supplement (HOM-CASE) to the CARE Clinical Case Reporting Guideline. Complementary Therapies in Medicine, 25, 78-85. https://doi.org/10.1016/j.ctim.2015.12.019 DOI: https://doi.org/10.1016/j.ctim.2015.12.019

Wight, J., & Paisley, S. (2003). The Epidemiology of Inhibitors in Haemophilia A: A Systematic Review. Haemophilia, 9(4), 418-435. https://doi.org/10.1046/j.1365-2516.2003.00780.x DOI: https://doi.org/10.1046/j.1365-2516.2003.00780.x